SE7612262L - KETOPHOSPHONATE INTERMEDIATE PRODUCTS AND PROCEDURES - Google Patents

KETOPHOSPHONATE INTERMEDIATE PRODUCTS AND PROCEDURES

Info

Publication number
SE7612262L
SE7612262L SE7612262A SE7612262A SE7612262L SE 7612262 L SE7612262 L SE 7612262L SE 7612262 A SE7612262 A SE 7612262A SE 7612262 A SE7612262 A SE 7612262A SE 7612262 L SE7612262 L SE 7612262L
Authority
SE
Sweden
Prior art keywords
alpha
trans
dimethylisopropylsilyloxy
pentanor
indanyl
Prior art date
Application number
SE7612262A
Other languages
Swedish (sv)
Inventor
H-J E Hess
T K Schaaf
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7612262L publication Critical patent/SE7612262L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/30Compounds having groups
    • C07C43/315Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/34Unsaturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

1456838 Silylated prostaglandins PFIZER Inc 8 Nov 1973 [8 Nov 1972] 51997/73 Heading C3S [Also in Division C2] N - Methansulphonyl - 15 - (5,6 - dimethoxy- 2 - indanyl) - 9α,11α,15# - tris - (dimethylisopropylsilyloxy) - 16,17,18,19,20 - pentanor - 13 - trans-prostenamide is prepared by hydrogenating N-methanesulphonyl-15-(5,6-dimethoxy-2- indanyl) - 9α,11α,15# - tris - (dimethylisopropylsilyloxy) - 16,17,18,19,20 - pentanor - 5 - cis, 13- trans-prostadienamide, resulting from the reaction between dimethylisopropylchlorosilane and N - methanesulphonyl - 9α,11α,15# - trihydroxy - 16,17,18,19,20 - pentanor - 5 - cis, 13- trans - prostadienamide. 16 - (2 - Indonyl)- 11α,15α - bis - (dimethylisopropylsilyloxy) - 9- oxo - 17,18,19,20 - tetranor - 13 - trans - prostenoic acid and 16-(2-indanyl)-11α,15α-bis-(dimethylisopropylsilyloxy) - 9 - oxo - 17,18.19,20- tetranor-5-cis, 13-trans-prostadienoic acid are obtained in a similar manner.
SE7612262A 1972-11-08 1976-11-03 KETOPHOSPHONATE INTERMEDIATE PRODUCTS AND PROCEDURES SE7612262L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30475072A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
SE7612262L true SE7612262L (en) 1976-11-03

Family

ID=23177829

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7315074A SE412229B (en) 1972-11-08 1973-11-06 ANALOGY PROCEDURE FOR PREPARING CERTAIN OMEGA-SUBSTITUTED PROSTAGLANDIN ANALOGS
SE7612261A SE7612261L (en) 1972-11-08 1976-11-03 PROSTAGLAND INTERMEDIATE PRODUCTS
SE7612262A SE7612262L (en) 1972-11-08 1976-11-03 KETOPHOSPHONATE INTERMEDIATE PRODUCTS AND PROCEDURES
SE7701523A SE417957B (en) 1972-11-08 1977-02-10 OMEGA-SUBSTITUTED PROSTAGLANDIN ANALOGUES FOR USE AS ANTIFERTILITY AGENT

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE7315074A SE412229B (en) 1972-11-08 1973-11-06 ANALOGY PROCEDURE FOR PREPARING CERTAIN OMEGA-SUBSTITUTED PROSTAGLANDIN ANALOGS
SE7612261A SE7612261L (en) 1972-11-08 1976-11-03 PROSTAGLAND INTERMEDIATE PRODUCTS

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7701523A SE417957B (en) 1972-11-08 1977-02-10 OMEGA-SUBSTITUTED PROSTAGLANDIN ANALOGUES FOR USE AS ANTIFERTILITY AGENT

Country Status (20)

Country Link
JP (1) JPS5714347B2 (en)
AT (1) AT345999B (en)
BE (1) BE807046A (en)
CA (1) CA1033727A (en)
CH (1) CH593930A5 (en)
DE (1) DE2355731C3 (en)
DK (1) DK143499C (en)
ES (3) ES420386A1 (en)
FI (1) FI58912C (en)
FR (3) FR2205338B1 (en)
GB (1) GB1456838A (en)
IE (1) IE40043B1 (en)
IL (2) IL43571A (en)
IN (1) IN139265B (en)
NL (1) NL7315307A (en)
NO (2) NO143663C (en)
PH (2) PH13261A (en)
SE (4) SE412229B (en)
SU (2) SU667131A3 (en)
ZA (1) ZA738595B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
JPS5823393B2 (en) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ prostaglandin
US4028396A (en) * 1975-07-02 1977-06-07 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
NZ183136A (en) * 1976-02-11 1978-11-13 Miles Lab Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions
US4074063A (en) * 1976-02-11 1978-02-14 Miles Laboratories, Inc. Bicycloalkyl derivatives of prostaglandins
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
DE2753995A1 (en) * 1977-12-03 1979-06-07 Bayer Ag NEW BICYCLOALKENYL PROSTAGLANDINS AND THE METHOD OF MANUFACTURING THEM
CN1269786A (en) * 1997-09-09 2000-10-11 普罗克特和甘保尔公司 Aromatic C16-C20 substituted tetrahydro prostaglandins useful as EP agonists
US6107338A (en) * 1997-09-09 2000-08-22 The Procter & Gamble Company Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists
BR9812631A (en) * 1997-09-09 2000-08-22 Procter & Gamble Tetrahydro prostaglandins replaced by aromatic c16-c20 useful as fp agonists
EP1159266B1 (en) 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
ATE432910T1 (en) * 2007-11-28 2009-06-15 Bauer Maschinen Gmbh WINDS
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20230097470A1 (en) * 2021-08-23 2023-03-30 Chirogate International Inc. Processes and intermediates for the preparations of carboprost and carboprost tromethamine, and carboprost tromethamine prepared therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4864073A (en) * 1971-04-30 1973-09-05

Also Published As

Publication number Publication date
FR2205338A1 (en) 1974-05-31
IN139265B (en) 1976-05-29
NO143663B (en) 1980-12-15
NL7315307A (en) 1974-05-10
ES456279A1 (en) 1978-11-01
NO743616L (en) 1974-05-09
SU704456A3 (en) 1979-12-15
JPS49133357A (en) 1974-12-21
PH13320A (en) 1980-03-13
SE417957B (en) 1981-04-27
DK143499B (en) 1981-08-31
NO143663C (en) 1981-03-25
BE807046A (en) 1974-05-08
CA1033727A (en) 1978-06-27
DK143499C (en) 1982-01-11
FI58912C (en) 1981-05-11
FI58912B (en) 1981-01-30
FR2286147B1 (en) 1978-09-22
DE2355731B2 (en) 1980-04-30
IL43571A0 (en) 1974-03-14
DE2355731C3 (en) 1981-01-15
FR2291200B1 (en) 1979-01-05
IE40043B1 (en) 1979-02-28
CH593930A5 (en) 1977-12-30
ES444398A1 (en) 1977-12-01
GB1456838A (en) 1976-11-24
FR2286147A1 (en) 1976-04-23
JPS5714347B2 (en) 1982-03-24
IL43571A (en) 1977-08-31
SE7612261L (en) 1976-11-03
IL50310A (en) 1977-08-31
NO144385B (en) 1981-05-11
FR2205338B1 (en) 1978-07-13
IE40043L (en) 1974-05-08
DE2355731A1 (en) 1974-05-22
FR2291200A1 (en) 1976-06-11
SE412229B (en) 1980-02-25
SE7701523L (en) 1977-02-10
ES420386A1 (en) 1976-07-01
NO144385C (en) 1981-08-19
PH13261A (en) 1980-02-25
AU6230273A (en) 1975-05-08
SU667131A3 (en) 1979-06-05
AT345999B (en) 1978-10-10
ATA941073A (en) 1978-02-15
ZA738595B (en) 1974-09-25

Similar Documents

Publication Publication Date Title
SE7612262L (en) KETOPHOSPHONATE INTERMEDIATE PRODUCTS AND PROCEDURES
GB1409841A (en) Prostaglandins and the manufacture thereof
NL7503654A (en) PROSTAGLANDIN DERIVATIVES.
AU3474371A (en) Mutanase, an alpha-1, 3-glucanese, a process forthe preparation thereof aswell ascertain uses ofthe said mutanese
ES444046A1 (en) Prostanoic acid derivatives
SE7705945L (en) CYCLOPENTAN DERIVATIVES
AU473283B2 (en) 8,12 prostaglandin analogues
ES430950A1 (en) 4-Hydroxy-3-nitro-5,6,7,8 tetrahydro-carbostyrils
NO142789C (en) PROCEDURE FOR THE PREPARATION OF A POLYPEPTIDE ANTIBIOTIC, GARDIMYCIN.
SU604492A3 (en) Method of preparing pyrimidineaminomethylergoline derivatives
IT1052622B (en) PROCEDURE FOR PRODUCING I. PURE NITROANTRACHINONE
AU472988B2 (en) Cycloalkylidenol & cycloalkenol analogues of prostaglandins e & f
CA1034521A (en) PROCESS FOR THE PREPARATION OF 17-ACYL ESTERS OF 17.alpha.,21-DIHYDROXYSTEROIDS OF THE PREGNANE SERIES
SU483178A1 (en) Cutter for the single issue of blanks
AU476756B2 (en) PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID
GB1377036A (en) Process for the manufacture of a cast floor covering based on anhydrite
SE394815B (en) METHOD OF PREPARING CERTAIN STATEMENTS (3-BENZO-1,2,4-TRIAZINYL-DIOXIDE-1,4) URBAMIDES
ES205281Y (en) CLINICAL TABLE CONVERTIBLE INTO TABLE.
NO141158C (en) PROCEDURE FOR THE PREPARATION OF PURE TERTIARY OLEFINES.
CA874983A (en) SYNTHESIS OF N,N-DISUBSTITUTED .alpha.-AMINOACETYLENE THIOETHERS
AU462331B2 (en) Synthesis of 1, 2-butadiene
AU8518775A (en) N, n'disubstituted naphthaleneacetamidines
AU461122B2 (en) S-2, 2' methylene-bis-3 (y-amino) 1, 2-propanediol
CA968792A (en) Stereospecific reduction of 9,15-diketo prostaglandins
CA1028352A (en) PREPARATION OF .alpha.,3-DICHLORO-4-CYCLOHEXYLPHENYL-ACETIC ACID

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7612262-1